Interim Trial Data Hints at Efficacy of ANVS401

[JayPwP]

parkinsonsnewstoday.com/202...

ANVS401, an investigational therapy for neurodegenerative diseases being developed by Annovis Bio, improved the speed and coordination of people with Parkinson’s disease in a Phase 2a clinical trial, an interim analysis suggests.

[park_bear]

Posted already once before, so far. Link to the actual press release upon which this news item was based:

irpages2.eqs.com/websites/a...

Company gives P values for improvements but does not state actual amount of improvement, which suggests that these numbers are unimpressive.

[jeffmayer]

Here's hoping and praying

[Hidden]

healthunlocked.com/cure-par...